-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amended.pdf
September 25, 2024 - • Psychological flexibility (e.g., AFQ-Y, AAQ)
• Healthcare utilization
Timing • A minimum of 4 weeks … report outcomes at various time points, which we will aggregate into the following
intervals: 4 to <8 weeks … , 8 to <12 weeks, 12 weeks to <6 months, 6 months to <12 months, and ≥12
months since the beginning
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
January 01, 2024 - study entry, previous therapy for prostate cancer other than biopsy or transurethral resection, > 12 weeks … preclude obtaining informed consent or adherence to protocol; inability to commence radiotherapy within 26 weeks … NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR No NR No NR NR 8.8
Norkus, 2009 NA NA KQ1 RCT NR (weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - consider adding
2 further outcomes in relation to the duration of
gestation; early preterm birth <34 weeks … and
prolonged gestation >42 weeks. … We did not identify any studies that
assessed the risk for late term births (>42
weeks) and only 1 … study appears to have
reported the incidence of early preterm
births (<34 weeks); we report this
outcome … but
did for preterm births < 34
weeks gestation (RR 0.99; 95% CI: 0.9, 1.1).
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - that the weight loss percentage of 8.0% to 8.9% reported in a study for naltrexone/bupropion at
56 weeks … mimic the effects of GI bypass surgery.
53
The device is intended to
remain in place for 12 to 24 weeks … reported that implantation was successful in 26 of 30 patients; however, the
device was removed after 12 weeks … The study reported results on 17 obese patients with T2DM who received
EndoBarrier for 24 weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - mg/dL [-38.4 mg/dL to -33.8 mg/dL]), and body
weight (-2.5 kg [-2.8 kg to -2.3 kg]) after 24 to 30 weeks … T2DM inadequately
controlled with metformin.88 Stage I (n=155) evaluated patient outcomes after 12 weeks … the following results in May 2013:88
HbA1c was significantly lower in all groups after 12 and 24 weeks … Weight was reduced by 2.8-3.7 kg (P < 0.05) at 24 weeks in all
except the 20→20 μg/day group. … Benefit
occurred for both doses compared with sham at 3 weeks and all subsequent time
points.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
May 01, 2015 - Down syndrome, or craniofacial abnormalities were excluded ,as were studies of
premature babies (<37 weeks … ascertainment of the outcomes was not
specifically reported, but outcomes were obtained within
the first 4 weeks … 6
days of age showed a significant reduction in maternal
pain.13 Those performed on infants a few weeks … later
frenotomy on nipple pain may relate to cumulative trauma
on the breast from several additional weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
April 28, 2010 - 1
Comparative Effectiveness Review
Number 64
Screening, Behavioral Counseling, and Referral
in Primary Care To Reduce Alcohol Misuse
Executive Summary
Background
Alcohol misuse, which includes the
full spectrum from drinking above
recommended limits (i.e., risky/hazardous
drinking) to alcohol dependence,1-3 …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
January 01, 2024 - 12 weeks NR 164 99 164 NR NR NR 62 60 (46, 67) 15 (24.2) NR 47 61 (46, 67) 11 (23.4) NR 55 56 (41, 64 … 8 weeks None; continued use of existing KSD prevention medications was permitted as long as there were … no dose changes planned or within the 8 weeks prior to study entry
N (%) using calcium for KSD risk … None 4 weeks per protocol Adherence to the study drug based on pill counts exceeded 96% Results were … reported but are not eligible because they were only reported at 8 weeks NR NR Results were reported
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
September 01, 2017 - Craving; cue reactivity
Timing/
Length of
follow-up
At least 12 weeks of follow up from the time … Less than 12 weeks
Settings Outpatient health care (i.e., non-laboratory) settings,
including studies … We would appreciate
hearing back from you in the next two weeks (by August 11, 2017). … Of concern, anxiety increased over time in
baclofen patients, from 5% during titration (weeks
1-7) … to 16% during taper-off (weeks 24-26.)43
An RCT of baclofen in veterans with Hepatitis C
(n=180) reported
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
December 01, 2015 - The draft report was
posted on the AHRQ Web site for 4 weeks to elicit public
comment. … Given the limited impact on
weight and the short length of treatment (6 to 12 weeks),
finding no difference … short studies
(e.g., outcomes measured only at end of treatment, which
could be just a matter of weeks
-
effectivehealthcare.ahrq.gov/health-topics/sinusitis
-
effectivehealthcare.ahrq.gov/health-topics/postpartum-care
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/partial-breast-irradiation-disposition-comments.pdf
January 31, 2023 - Conventionally fractionated WBI has largely been
supplanted by hypofractionation completed over approximately 3 weeks … compared with a hypofractionated WBRT control that is gentler on
the normal tissues - 40Gy in 15F over 3 weeks … This is compared to “traditional” dose/fractionated RT over ~6 weeks,
a point which needs to be highlighted
-
effectivehealthcare.ahrq.gov/sites/default/files/s3.pdf
October 01, 2007 - Against this backdrop, Harry stood out on that first
morning and throughout the following 6 weeks of
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
April 01, 2020 - This review
required studies of cognition and function to be
at least 24 weeks long, and studies of … agitation,
aggression, and psychosis to be at least 2 weeks
long; trials reporting only on acute and … In addition,
few included trials were longer than 26 weeks, so
longer-term drug effects were unclear … analyses due to high risk of
bias, often because of high attrition, especially
trials longer than 26 weeks … treatment efficacy and harms of prescription drugs
in patients with CATD and BPSD and were at least
2 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
January 01, 2012 - participants who were smokers, the study authors reported that
14.3% of the participants quit smoking at 4 weeks … arm.
5
The trial is expected to enroll 500
participants and to gather followup cessation data at 6 weeks … problems of low adherence and medication diversion because the drugs’ effects may last for several
weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
May 01, 2024 - with carbapenem,
3rd- or 4th-
generation
cephalosporin,
or fluoroquinolone
for >3 days during
2 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
January 01, 2023 - healthcare is provided Dedicated PP visit, part of well-child visit
3 When healthcare is provided 2 weeks … , 6 weeks
4 Who provides healthcare/support
Predominantly health system-based care
Predominantly community-based
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
April 01, 2011 - double-blind placebo
controlled trial with block randomization, in which
treatment was administered for 10 weeks … in 54 patients; however,
low response rates resulted in a study extension for 26
participants to 10 weeks … Among participants with data at 10 weeks,
46.2 percent were responders and 26.9 were in
remission.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-executive-summary.pdf
May 01, 2024 - In adults with chronic migraine, behavioral sleep modification may reduce
headache frequency at 6 weeks